Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Wel, T. van der"'
Autor:
Berger, N., Wel, T. van der, Hirschmugl, B., Baernthaler, T., Gindlhuber, J., Fawzy, N., Eichmann, T., Birner-Gruenberger, R., Zimmermann, R., Stelt, M. van der, Wadsack, C.
IntroductionLipids and fatty acids are key components in metabolic processes of the human placenta, thereby contributing to the development of the fetus. Placental dyslipidemia and aberrant activity of lipases have been linked to diverse pregnancy as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______202::eb397f85667146a26bcb5a2d864214c7
https://hdl.handle.net/1887/3631029
https://hdl.handle.net/1887/3631029
Autor:
Gagestein, B., Stevens, A.F., Fazio, D., Florea, B.I., Wel, T. van der, Bakker, A.T., Fezza, F., Dulk, J. den, Overkleeft, H.S., Maccarrone, M., Stelt, M. van der
Publikováno v:
ACS Chemical Biology, 17(5), 1174-1183
Anandamide or N-arachidonoylethanolamine (AEA) is a signaling lipid that modulates neurotransmitter release via activation of the type 1 cannabinoid receptor (CB1R) in the brain. Termination of anandamide signaling is thought to be mediated via a fac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::deba41cfa36b710147ddddadcbeca011
http://hdl.handle.net/11697/192025
http://hdl.handle.net/11697/192025
Autor:
Wel, T. van der
Publikováno v:
None
Drug development is a time- and resource-consuming process that starts with the discovery and validation of a (protein) target that contributes to pathogenesis or disease progression. One of the essential steps in this process is to validate that pha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::aa11254a7f81a05de648ff310e5d2fdc
http://hdl.handle.net/1887/83257
http://hdl.handle.net/1887/83257